The global cannabis testing services market is projected to expand from $2.5 billion in 2024 to over $12 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 17.26%.
This growth is fueled by the increasing legalization of cannabis worldwide, heightened awareness of safety and quality standards, and advancements in testing technologies, according to a new Research and Markets report.
Legalization for medical and recreational cannabis in regions such as the United States, Canada, and parts of Europe and Asia has led to a surge in demand for comprehensive testing services, notes the report. Currently, 39 U.S. states allow medical marijuana, with 24 states also legalizing recreational use. These changes underscore the importance of reliable testing to meet evolving regulatory requirements.
Among testing services, potency testing leads in revenue generation, driven by the need to accurately measure THC and CBD levels for compliance and consumer safety. Innovations like the Trust in Testing Certification, introduced by ACT Laboratories and SC Labs, highlight the industry’s push for standardized testing protocols. Meanwhile, flower testing dominates sample types due to its prevalence in the market, with extracts showing the fastest growth, thanks to their use in edibles and concentrates.
Regionally, North America commands the largest market share due to established testing labs and stringent regulations. The Asia Pacific region, however, is expected to grow at the fastest rate, spurred by the adoption of medical cannabis in countries like Thailand and Japan.
As cannabis legalization continues to spread, the industry’s focus on rigorous testing will remain essential to ensure product quality, consumer safety, and regulatory compliance. For more information on this report, click here.
